Atlas Trials

The RECAP2 Study: Midazolam and Psilocybin

Clinical trial NCT06692192 · RECRUITING

Trial details

NCT number
NCT06692192
Sponsor
University of Wisconsin, Madison
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Psilocybin
Start date
2025-08-07
Primary completion
2027-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.